Systemic Senescence Reversal is a complex, multi-modal clinical strategy aimed at clearing senescent, or “zombie,” cells from various tissues throughout the body and restoring the proliferative capacity of healthy cells. Senescent cells accumulate with age, secreting a pro-inflammatory cocktail known as the Senescence-Associated Secretory Phenotype (SASP), which drives chronic inflammation and tissue dysfunction. The goal of reversal is to reduce this systemic inflammatory burden, thereby improving tissue function and extending healthspan.
Origin
This term is a core concept in modern longevity medicine, directly derived from the discovery and clinical targeting of cellular senescence as a fundamental hallmark of aging. It moves beyond simple antioxidant strategies to directly address the biological cause of age-related systemic decline. The clinical application of senolytic agents, which selectively kill senescent cells, is central to this reversal framework.
Mechanism
The primary mechanism involves the therapeutic use of senolytic compounds that selectively induce apoptosis, or programmed cell death, in senescent cells by targeting their unique anti-apoptotic pathways. Once cleared, the inflammatory SASP is reduced, allowing for the regeneration of healthy tissue and the restoration of normal cellular function. This reduction in chronic, low-grade inflammation is key to improving metabolic health, immune function, and overall tissue integrity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.